Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Chrystal U, Louis"'
Autor:
Daniel A. Pollyea, Tracy I. George, Mehrdad Abedi, Rafael Bejar, Christopher R. Cogle, Kathryn Foucar, Guillermo Garcia‐Manero, David L. Grinblatt, Rami S. Komrokji, Jaroslaw P. Maciejewski, Dennis A. Revicki, Gail J. Roboz, Michael R. Savona, Bart L. Scott, Mikkael A. Sekeres, Michael A. Thompson, Sandra E. Kurtin, Chrystal U. Louis, Melissa Nifenecker, E. Dawn Flick, Arlene S. Swern, Pavel Kiselev, David P. Steensma, Harry P. Erba
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 58-68 (2020)
Abstract Diagnostic and molecular genetic testing are key in advancing the treatment of acute myeloid leukemia (AML), yet little is known about testing patterns outside of clinical trials, especially in older patients. We analyzed diagnostic and mole
Externí odkaz:
https://doaj.org/article/b36efed85da84efcbaf5ae149d394d44
Autor:
Jonathan W. Goldman, David M. Waterhouse, Ben George, Peter J. O'Dwyer, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin Ong, Karen Kelly
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Multicenter, phase I study of concurrent and delayed nivolumab plus nab-paclitaxel/carboplatin in advanced non-small cell lung cancer (NSCLC).Methods: Chemotherapy-naive patients with advanced NSCLC (ineligible for potentially curative
Externí odkaz:
https://doaj.org/article/36deb3212f774536b9f45353cdf8f360
Autor:
Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, Michael A. Thompson, David L. Grinblatt, Daniel A. Pollyea, Rami S. Komrokji, Gail J. Roboz, Michael R. Savona, Mikkael A. Sekeres, Mehrdad Abedi, Guillermo Garcia-Manero, Sandra E. Kurtin, Jaroslaw P. Maciejewski, Jay L. Patel, Dennis A. Revicki, Tracy I. George, E. Dawn Flick, Pavel Kiselev, Chrystal U. Louis, Irene S. DeGutis, Melissa Nifenecker, Harry P. Erba, David P. Steensma, Bart L. Scott
Publikováno v:
Transplantation and Cellular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::596436d84ba44c48c9839e040b820064
https://doi.org/10.1016/j.jtct.2023.04.011
https://doi.org/10.1016/j.jtct.2023.04.011
Autor:
Peter J. O'Dwyer, Teng Jin Ong, Chrystal U. Louis, Larry Lyons, Sibabrata Banerjee, Rafia Bhore, Daniel W. Pierce, David J. Reiss, Thomas Lila, Hatem H. Soliman, Daniel Ricardo Carrizosa, Rishi Jain, Aparna Parikh, Martin Guiterrez, David M. Waterhouse, E. Gabriela Chiorean, Aparna Kaylan, Ben George, Edward J. Kim, Howard S. Hochster, Zev A. Wainberg
Baseline (screening) vs treatment cycle 2 (P=.06; paired t test). For patient 5, baseline data were not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd98b63eb49f579d01cbe44a0a85231
https://doi.org/10.1158/1078-0432.22475423
https://doi.org/10.1158/1078-0432.22475423
Autor:
Peter J. O'Dwyer, Teng Jin Ong, Chrystal U. Louis, Larry Lyons, Sibabrata Banerjee, Rafia Bhore, Daniel W. Pierce, David J. Reiss, Thomas Lila, Hatem H. Soliman, Daniel Ricardo Carrizosa, Rishi Jain, Aparna Parikh, Martin Guiterrez, David M. Waterhouse, E. Gabriela Chiorean, Aparna Kaylan, Ben George, Edward J. Kim, Howard S. Hochster, Zev A. Wainberg
Purpose:Assess safety and efficacy of nivolumab plus nab-paclitaxel and gemcitabine in patients with locally advanced/metastatic pancreatic cancer in a two-part, open-label, phase I trial.Patients and Methods:Fifty chemotherapy-naive patients receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91944ff29f7b99aa8e56f618a1dd6950
https://doi.org/10.1158/1078-0432.c.6529076.v1
https://doi.org/10.1158/1078-0432.c.6529076.v1
Autor:
Peter J. O'Dwyer, Teng Jin Ong, Chrystal U. Louis, Larry Lyons, Sibabrata Banerjee, Rafia Bhore, Daniel W. Pierce, David J. Reiss, Thomas Lila, Hatem H. Soliman, Daniel Ricardo Carrizosa, Rishi Jain, Aparna Parikh, Martin Guiterrez, David M. Waterhouse, E. Gabriela Chiorean, Aparna Kaylan, Ben George, Edward J. Kim, Howard S. Hochster, Zev A. Wainberg
Percentage lymphocyte subset Ki67+. All patient visits are binned by treatment cycle. Data at baseline and treatment cycle 3 were compared using the Wilcoxon signed rank test. All available data are illustrated; however, statistical comparisons were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af451ccc2b3f88d0ca2643cefe85947
https://doi.org/10.1158/1078-0432.22475429
https://doi.org/10.1158/1078-0432.22475429
Autor:
Alexey A. Lugovskoy, Vasileios Askoxylakis, Robert M. Straubinger, J. Marc Pipas, Birgit Schoeberl, Ulrik B. Nielsen, Daryl C. Drummond, Chrystal U. Louis, Akos Czibere, Charlene Minx, Jason Baum, Sergio Iadevaia, Troy Bloom, Gege Tan, Lin Nie, Victoria Rimkunas, Michael D. Curley, Sharlene Adams, Emily A. Pace, Adam J. Camblin
Supplemental Figure S2: Istiratumab inhibits growth factor-induced AKT phosphorylation across a pancreatic cancer cell line panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56fbe3030b674cb44ac8311785ed7e8d
https://doi.org/10.1158/1078-0432.22465556
https://doi.org/10.1158/1078-0432.22465556
Autor:
Alexey A. Lugovskoy, Vasileios Askoxylakis, Robert M. Straubinger, J. Marc Pipas, Birgit Schoeberl, Ulrik B. Nielsen, Daryl C. Drummond, Chrystal U. Louis, Akos Czibere, Charlene Minx, Jason Baum, Sergio Iadevaia, Troy Bloom, Gege Tan, Lin Nie, Victoria Rimkunas, Michael D. Curley, Sharlene Adams, Emily A. Pace, Adam J. Camblin
Table S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9363760c6e52df414b79366e520ff74c
https://doi.org/10.1158/1078-0432.22465529
https://doi.org/10.1158/1078-0432.22465529
Autor:
Peter J. O'Dwyer, Teng Jin Ong, Chrystal U. Louis, Larry Lyons, Sibabrata Banerjee, Rafia Bhore, Daniel W. Pierce, David J. Reiss, Thomas Lila, Hatem H. Soliman, Daniel Ricardo Carrizosa, Rishi Jain, Aparna Parikh, Martin Guiterrez, David M. Waterhouse, E. Gabriela Chiorean, Aparna Kaylan, Ben George, Edward J. Kim, Howard S. Hochster, Zev A. Wainberg
T-Cell Tumor Infiltration in Tissue-Matched Baseline (screening) and On-Treatment Metastatic Tumors (arm B parts 1 and 2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5462aa83ef7e3c2c1c1145183bef1b4
https://doi.org/10.1158/1078-0432.22475426
https://doi.org/10.1158/1078-0432.22475426
Autor:
Alexey A. Lugovskoy, Vasileios Askoxylakis, Robert M. Straubinger, J. Marc Pipas, Birgit Schoeberl, Ulrik B. Nielsen, Daryl C. Drummond, Chrystal U. Louis, Akos Czibere, Charlene Minx, Jason Baum, Sergio Iadevaia, Troy Bloom, Gege Tan, Lin Nie, Victoria Rimkunas, Michael D. Curley, Sharlene Adams, Emily A. Pace, Adam J. Camblin
Purpose: Insulin-like growth factor receptor 1 (IGF-1R) is critically involved in pancreatic cancer pathophysiology, promoting cancer cell survival and therapeutic resistance. Assessment of IGF-1R inhibitors in combination with standard-of-care chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67565d75c08617bb5e48fee4d51b15c3
https://doi.org/10.1158/1078-0432.c.6526055.v1
https://doi.org/10.1158/1078-0432.c.6526055.v1